Skip to main content
logo
Vicore Pharma Holding AB (publ) (VCRE)
NASDAQ: VCRE · Real-Time Price · USD
12.00
+0.41 (3.54%)
Sep 8, 2026, 10:36 AM EDT - Market open

Vicore Pharma Holding AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.993.82109.35---
Revenue Growth
-48.41%-96.51%----
Gross Profit
3.993.82109.35---
Operating Income
-523.89-454.45-190.36-320.89-287.49-293.42
Net Income
-502.04-477.47-168.63-310.94-288.42-296.48
Earnings Per Share
-1.91-1.99-1.23-3.22-3.99-4.25
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
905.641,1671,156482.77261.74371.48
Total Debt
----0.070.32
Net Cash (Debt)
905.641,1671,156482.77261.68371.16
Net Cash Growth
-3.35%0.93%139.45%84.49%-29.50%16.50%
Net Cash Per Share
3.444.868.455.003.625.33

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-456.73-375.74-164.95-249.58-299.92-265.17
Capital Expenditures
------
Free Cash Flow
-456.73-375.74-164.95-249.58-299.92-265.17
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%---
Operating Margin
-13116.97%-11905.82%-174.09%---
Pretax Margin
-12563.27%-12509.14%-154.45%---
Profit Margin
-12569.76%-12509.14%-154.22%---
FCF Margin
-11435.40%-9843.78%-150.85%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
783.57833.4418.13---